Literature DB >> 10733616

Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset.

.   

Abstract

Objective: RLS varies considerably in both frequency of occurrence in a family and in age of onset of symptoms. Patients whose RLS symptoms start before or at age 45 have many more affected relatives than those whose symptoms start later, suggesting etiological differences. When etiology differs, factors affecting severity may differ. This study compares the effects of current age and serum ferritin on RLS severity for early- and late-onset (over 45) RLS.Design and methods: RLS severity was evaluated using a validated clinical severity scale and sleep efficiency on a standard polysomnogram. Data from 26 consecutive RLS patients (14 early- and 12 late-onset) who met study criteria were analyzed.
Results: Age-of-onset groups showed no significant differences in age, gender and RLS symptom severity. Regression analyses showed significant (P<0.05) differences with RLS severity primarily affected by age for early-onset RLS and by serum ferritin for late-onset RLS.Conclusions: The age effect for early-onset RLS indicates a slowly progressive disorder. Thus early-onset RLS appears to occur commonly in families, slowly progress with age and have a limited relation to serum iron status. In contrast, late-onset RLS appears to occur less commonly in families, rapidly progress with age and have a strong relation to serum iron status. Age of symptom onset should be considered to better define the RLS phenotype in future studies.

Entities:  

Year:  2000        PMID: 10733616     DOI: 10.1016/s1389-9457(99)00012-x

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  27 in total

Review 1.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

2.  Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  Giovanni Merlino; Simone Lorenzut; Giulio Romano; Martina Sommaro; Augusto Fontana; Domenico Montanaro; Mariarosaria Valente; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2012-01-22       Impact factor: 3.307

3.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

4.  Restless legs syndrome: a unique case and essentials of diagnosis and treatment.

Authors:  Pinky Agarwal; Alida Griffith
Journal:  Medscape J Med       Date:  2008-12-31

5.  Analysis of familial and sporadic restless legs syndrome in age of onset, gender, and severity features.

Authors:  Melissa Hanson; Melissa Honour; Amanda Singleton; Anthony Crawley; Andrew Singleton; John Hardy; Katrina Gwinn-Hardy
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 6.  Restless legs syndrome and pregnancy: a review.

Authors:  Prachaya Srivanitchapoom; Sanjay Pandey; Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2014-04-08       Impact factor: 4.891

7.  Association of Restless Legs Syndrome With Incident Parkinson's Disease.

Authors:  Szabolcs Szatmari; Daniel Bereczki; Katalin Fornadi; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar
Journal:  Sleep       Date:  2017-02-01       Impact factor: 5.849

8.  Epidemiology of restless legs syndrome in Korean adults.

Authors:  Yong Won Cho; Won Chul Shin; Chang Ho Yun; Sung Bong Hong; Ju Han Kim; Richard P Allen; Christopher J Earley
Journal:  Sleep       Date:  2008-02       Impact factor: 5.849

9.  Treatment of restless legs syndrome.

Authors:  Silvia Rios Romenets; Ronald B Postuma
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

10.  Validation of the Restless Legs Syndrome Quality of Life Instrument (RLS-QLI): findings of a consortium of national experts and the RLS Foundation.

Authors:  M J Atkinson; R P Allen; J DuChane; C Murray; C Kushida; T Roth
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.